Japan· JP-2229004F1030
クロペラスチン塩酸塩
A cloperastine product containing クロペラスチン塩酸塩, registered in Japan by ニプロ, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Cloperastine is registered in 3 of 19 countries.
Countries holding a registration under ATC R05DB21 (cloperastine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Cloperastine · ATC R05DB21
3 / 19 countries
- Belgiumprice
- Japan
- Spainprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- クロペラスチン塩酸塩
- Manufacturer
- ニプロ
- Country
- Japan (JP)
- ATC code
- R05DB21
- ATC class
- Cloperastine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R05DB21
Cloperastine, as other registers publish it.
- SpainCLOPERASTINA KERN PHARMA 3,54 mg/ml JARABEKern Pharma S.L.
- SpainCLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORALLaboratorios Normon S.A.
- BelgiumLysotossil 10 mgZambon
- BelgiumLysotossil 3.54 mg/mlZambon
- BelgiumSekin 10 mgAlmirall
- BelgiumSekin 3.54 mg/mlAlmirall
- Japanクロペラスチンフェンジゾ酸塩ニプロ
- Japanクロペラスチンフェンジゾ酸塩ニプロ
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/27010b19-49cf-4c7c-9b9c-0808e4d9bb1c GET /v1/drugs/27010b19-49cf-4c7c-9b9c-0808e4d9bb1c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2229004F1030",
"category": "内用薬",
"price_yen": 6.3,
"generic_name": "クロペラスチン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2229",
"transitional_expiry": null
}See everything about cloperastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.